We show that, in addition to HE4 (which has been shown to be the second best performing marker after CA125 in the context of screening), glycodelin is a novel and useful adjunct to CA125 for early detection of ovarian cancer. This evidence concerns the gene WFDC2 and ovarian carcinoma.